SARS-CoV-2 coronavirus
December 2, 2022

This article was originally posted on the WCM Newsroom

In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-...

mosquito on skin
November 22, 2022

An unusual type of antibody that even at miniscule levels neutralizes the Zika virus and renders the virus infection...

Eric J. Mallack
November 3, 2022

Eric J. Mallack, M.D., Director of the Leukodystrophy Center and Assistant Professor of Pediatrics and Neurology at Weill Cornell Medicine is the Co-Principal Investigator of a new phase 2/3 clinical trial, sponsored by Minoryx Therapeutics. The “NEXUS” study will assess the efficacy and safety of leriglitazone in pediatric patients with early-stage...